Common GLP-1 agonists include: Semaglutide (Ozempic, Wegovy) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Tirzepatide (Zepbound) While initially used for diabetes management, studies showed that GLP-1 agonists also contribute significantly to weight loss, leading to their approval for obesity treatment as well
GLP-1 agonists could lead to worse metabolic health, including significant loss of muscle mass
Maximum Fat Loss Efficiency Burn more, store less
Below is the pattern that is not unique to Ozempic
Right skincare, healthy eating, and therapeutic epidermal disorders may result in a term that is better characterized by uniformity and good looks
Here's what we'll cover Here's what we'll cover Here's what we'll cover Key takeaways Ozempic (semaglutide) is a peptide, but not a biologic, because its structure contains fewer than 40 amino acids